Related references
Note: Only part of the references are listed.Bmi-1 over-expression in neural stem/progenitor cells increases proliferation and neurogenesis in culture but has little effect on these functions in vivo
Shenghui He et al.
DEVELOPMENTAL BIOLOGY (2009)
Bmi-1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrain
Christopher A. Fasano et al.
GENES & DEVELOPMENT (2009)
Pancreatic cancer stem cells
Cheong J. Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis
Kathy Lee et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Ezh2 requires PHF1 to efficiently catalyze h3 lysine 27 trimethylation in vivo
Kavitha Sarma et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Epigenetic interplay between histone modifications and DNA methylation in gene silencing
Thomas Vaissiere et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)
Bmi-1 cooperates with H-ras to transform human mammary epithelial cells via Dysregulation of multiple growth-regulatory pathways
Sonal Datta et al.
CANCER RESEARCH (2007)
Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
Jing Tan et al.
GENES & DEVELOPMENT (2007)
Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival
M. K. Kang et al.
BRITISH JOURNAL OF CANCER (2007)
Polycomb silencers control cell fate, development and cancer
Anke Sparmann et al.
NATURE REVIEWS CANCER (2006)
The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer
Outi R. Saramaki et al.
GENES CHROMOSOMES & CANCER (2006)
Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells
Li-Bing Song et al.
CANCER RESEARCH (2006)
Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate
N Khan et al.
CANCER RESEARCH (2006)
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
IM Bachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing
R Cao et al.
MOLECULAR CELL (2005)
Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder
JD Raman et al.
CLINICAL CANCER RESEARCH (2005)
A novel retinoid-related molecule inhibits pancreatic cancer cell proliferation by a retinoid receptor independent mechanism via suppression of cell cycle regulatory protein function and induction of caspase-associated apoptosis
S Balasubramanian et al.
ONCOGENE (2005)
Human epidermal keratinocytes undergo (-)-epigallocatechin-3-gallate-dependent differentiation but not apoptosis
S Balasubramanian et al.
CARCINOGENESIS (2005)
Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer
GV Glinsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors
FM Raaphorst
HUMAN MOLECULAR GENETICS (2005)
The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins
JH Kim et al.
CANCER LETTERS (2004)
Division of labor in Polycomb group repression
SS Levine et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Stem colls and cancer: The polycomb connection
ME Valk-Lingbeek et al.
CELL (2004)
SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex
R Cao et al.
MOLECULAR CELL (2004)
Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis
RHJ Breuer et al.
NEOPLASIA (2004)
Green tea polyphenol and curcumin inversely regulate human involucrin promoter activity via opposing effects on CCAAT/enhancer-binding protein function
S Balasubramanian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Recent advances in X-chromosome inactivation
E Heard
CURRENT OPINION IN CELL BIOLOGY (2004)
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
AP Bracken et al.
EMBO JOURNAL (2003)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 bv Polvcomb and HP1 chromodomains
W Fischle et al.
GENES & DEVELOPMENT (2003)
Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells
J Lessard et al.
NATURE (2003)
Polycomb, epigenomes, and control of cell identity
V Orlando
CELL (2003)
Signaling pathways transduced through the elastin receptor facilitate proliferation of arterial smooth muscle cells
S Mochizuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein
A Kuzmichev et al.
GENES & DEVELOPMENT (2002)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice
YP Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Green tea Polyphenol stimulates a Ras, MEKK1, MEK3, and p38 cascade to increase activator protein 1 factor-dependent involucrin gene expression in normal human keratinocytes
S Balasubramanian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma
FJ van Kemenade et al.
BLOOD (2001)
The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression
S Vonlanthen et al.
BRITISH JOURNAL OF CANCER (2001)
Regulation of the G2/M transition by p53
WR Taylor et al.
ONCOGENE (2001)
Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate
N Ahmad et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Cyclin-dependent kinase inhibitors: novel anticancer agents
S Mani et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)
Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease
FM Raaphorst et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)